Combating chronic inflammation through immune diagnostics

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Virax Biolabs on innovative approaches to monitoring cytokines, T cell dysfunction and oxidative stress for better healthspan management.

Virax Biolabs is a company at the forefront of revolutionizing immune diagnostics and longevity science. By focusing on the intricate relationship between the immune system and the aging process, Virax tackles two of the most pressing challenges in modern healthcare: chronic inflammation and immune dysfunction. These issues are not only key drivers of aging but also major contributors to age-related diseases such as cardiovascular conditions, neurodegenerative disorders, and metabolic syndromes. Virax’s mission is to provide innovative tools and insights that empower individuals to take control of their healthspan and address these critical areas proactively.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE